2024

1. Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study

   Clinical Infectious Diseases, Vol. 78, Núm. 2, pp. 476-483

2. Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain

   Influenza and other Respiratory Viruses, Vol. 18, Núm. 5

3. Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years

   Journal of Infection, Vol. 89, Núm. 5